Shares of EpiPen maker Mylan surged 7 percent in morning trade Wednesday, on the heels of the company reporting fourth-quarter earnings that topped Wall Street's expectations. Mylan reported adjusted earnings per …
CNBC1mon
Stock
What: Shares of the specialty and generic drugmaker Mylan (NASDAQ:MYL) fell by more than 14% today on heavy volume after Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) dropped its $40 billion hostile takeover …
The Motley Fool
U.S. stock indices closed slightly lower on Friday ... "We expect guidance to be reiterated despite a delay to Mylan's generic Advair, with launches still possible by mid year. This is likely to largely neutralise FY growth." …
Donald Trump
Mylan N.V. (Nasdaq: MYL) issued a Rule 2.4 announcement under the Irish Takeover Rules stating that it had made a non-binding proposal to acquire Perrigo (NYSE: PRGO) for US$205 in a combination of cash and …
Not surprisingly, the effect on Mylan’s stock has been negative ... So we ran it through the Investment U Fundamental Factor Test. (As a reminder, our checklist looks at six key metrics to diagnose the financial …
Stock
The scandal has market players wondering if MYL can be sold short aggressively as the next Valeant Pharmaceuticals international (VRX) trade. That now infamous stock has fallen from $260 into the upper teens …
Trade
Mylan NV shares sank 2.0% in afternoon trade Wednesday after the company said the Food and Drug Administration failed to approve its generic version of the asthma medication Advair Diskus, which is …
Asthma
... Shares of Mylan NV (MYL.O) are trading at historically low valuations as the company's chief executive officer is set to face a congressional grilling on Wednesday over the price of its EpiPen emergency allergy treatment. …
Reuters
On August 10th, the CEO of Mylan, Heather Bresch, assured that reliance on the Epipen was starting to ware down. This was the day the CEO was talking about earnings on the conference call. The CEO tried to …
Mylan could be facing another issue when it comes to the EpiPen, a drug used to treat severe allergic …
Overcharging